The DC maturation marker DC-SIGN was expressed on one third of dermal DCs from primary melanomas– implying a predominantly immature population of DCs, that may have reduced ability to stimulate effector CD8+ T cells [6]. This evidence concerns the gene CD209 and melanoma.